Monday, October 29, 2018 5:40:50 PM
https://rumormurmursbuzz.blogspot.com/2018/10/ceo-ian-read-to-confirm-pfizer-pfe.html
CEO Ian Read To Confirm Pfizer (PFE) Intent To Buyout Titan Pharmaceuticals (TTNP) As Probuphine Success Continues, Official PR Coming Prior To Thanksgiving
Rumors, Murmurs and Buzz presents the latest forecasts, predictions and rumors from the street on US equity markets. Enjoy the speculation but remember it's never wise to invest in any stock based on unsubstantiated speculative predictions or rumors.
CEO Ian Read To Confirm Pfizer (PFE) Intent To Buyout Titan Pharmaceuticals (TTNP) As Probuphine Success Continues, Official PR Coming Prior To Thanksgiving
Rumors, Murmurs and Buzz presents the latest forecasts, predictions and rumors from the street on US equity markets. Enjoy the speculation but remember it's never wise to invest in any stock based on unsubstantiated speculative predictions or rumors.
Recent TTNP News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 10/14/2025 08:05:15 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/09/2025 09:30:37 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/09/2025 09:30:34 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/09/2025 09:21:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2025 12:21:28 AM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 10/02/2025 12:47:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2025 08:05:34 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/22/2025 04:28:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/14/2025 09:16:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/22/2025 09:06:53 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 07/22/2025 09:04:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2025 08:15:19 PM
- Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 06/27/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2025 08:49:02 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/03/2025 09:25:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2025 09:25:13 PM
- Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. • GlobeNewswire Inc. • 06/03/2025 12:45:44 PM
